相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials
Katrina Witt et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial
Yoav Domany et al.
DEPRESSION AND ANXIETY (2020)
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression
Jennifer L. Phillips et al.
NEUROPSYCHOPHARMACOLOGY (2020)
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings
Taeho Greg Rhee et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
The association of trait impulsivity and suicidal ideation and its fluctuation in the context of the Interpersonal Theory of Suicide
Asim Hadzic et al.
COMPREHENSIVE PSYCHIATRY (2020)
The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Preventing suicide in the context of the COVID-19 pandemic
Roger S. McIntyre et al.
WORLD PSYCHIATRY (2020)
Impact of COVID-19 pandemic on mental health in the general population: A systematic review
Jiaqi Xiong et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Double-Blind, Randomized Study (ASPIRE I)
Dong-Jing Fu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
Yoav Domany et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial
Dawn F. Ionescu et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)
Mu-Hong Chen et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Hospital-presenting self-harm and ideation: Comparison of incidence, profile and risk of repetition
Eve Griffin et al.
GENERAL HOSPITAL PSYCHIATRY (2019)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
Somaye Arabzadeh et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Presentations to NSW emergency departments with self-harm, suicidal ideation, or intentional poisoning, 2010-2014
Jayashanki Perera et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2018)
Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting
Mark Sinyor et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
Cristina Cusin et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Francesco Bartoli et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial
Michael F. Grunebaum et al.
BIPOLAR DISORDERS (2017)
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Y. -D. Hu et al.
PSYCHOLOGICAL MEDICINE (2016)
Suicide, Suicide Attempts, and Suicidal Ideation
E. David Klonsky et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 12 (2016)
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
Morteza Jafarinia et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A New Perspective on the Anti-Suicide Effects With Ketamine Treatment A Procognitive Effect
Yena Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
A Double-Blinded, Randomized, Placebo-Controlled Sub-Dissociative Dose Ketamine Pilot Study in the Treatment of Acute Depression and Suicidality in a Military Emergency Department Setting
John Burger et al.
MILITARY MEDICINE (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S. Malhi et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
Lael Reinstatler et al.
DRUGS IN R&D (2015)
Systematic review and meta-analysis of transdiagnostic psychological treatments for anxiety and depressive disorders in adulthood
Jill M. Newby et al.
CLINICAL PSYCHOLOGY REVIEW (2015)
Existing and Novel Biological Therapeutics in Suicide Prevention
Joshua J. Griffiths et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2014)
Oral ketamine augmentation for chronic suicidality in treatment-resistant depression
Angelo De Gioannis et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
Rebecca B. Price et al.
DEPRESSION AND ANXIETY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims
Magdalena Sowa-Kucma et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Andrea Cipriani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Accelerating response to antidepressant treatment in depression: A review and clinical suggestions
Shinichiro Nakajima et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder
MA Oquendo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Clozapine treatment for suicidality in schizophrenia - International Suicide Prevention Trial (InterSePT)
HY Meltzer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
分享论文
